INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS

被引:57
作者
EICHELBAUM, M
WOOLHOUSE, NM
机构
[1] UNIV BONN, MED KLIN, SIGMUND FREUD STR 25, D-5300 BONN 1, FED REP GER
[2] UNIV GHANA, SCH MED, DEPT BIOCHEM, ACCRA, GHANA
关键词
D O I
10.1007/BF00635712
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sparteine oxidation, which exhibits genetic polymorphism in various Caucasian populations, was studied in 154 unrelated Ghanaian subjects. Mean total urinary recovery of sparteine and 2- and 5-dehydrosparteines (56.6 .+-. 16.6% of the dose) was not different from Caucasians. In contrast to Caucasians, among whom 6.3-9% of the population are poor metabolizers (PM), no PM subject was observed in the Ghanaian population sample. The data appear to indicate allelic differences between Caucasians and Ghanaians in the gene encoding the synthesis of the P-450 isozyme involved in polymorphic sparteine oxidation.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 29 条
  • [1] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
  • [2] DENGLER HJ, 1977, ARZNEIMITTEL-FORSCH, V27-2, P1836
  • [3] DICK B, 1982, SCHWEIZ MED WSCHR, V112, P1061
  • [4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
    EICHELBAUM, M
    SPANNBRUCKER, N
    STEINCKE, B
    DENGLER, HJ
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
  • [5] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
    EICHELBAUM, M
    BERTILSSON, L
    SAWE, J
    ZEKORN, C
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
  • [6] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
  • [7] EICHELBAUM M, 1978, BIOL OXIDATION NITRO
  • [8] EICHELBAUM M, 1984, FED PROC, V43, P98
  • [9] FUGURA K, 1973, CHEM PHARM BULL, V21, P231
  • [10] ISOLATION AND PURIFICATION OF CYTOCHROME-P-450, AND THE EXISTENCE OF MULTIPLE FORMS
    GUENGERICH, FP
    [J]. PHARMACOLOGY & THERAPEUTICS, 1979, 6 (01) : 99 - 121